2023 annual financial data
Janux Therapeutics 2023 Operating margin
Janux Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -902.87%.
Operating income was -72,979,000 USD and net income was -58,293,000 USD.
Operating cash flow was Not available.
Get free Janux Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,083,000 USD
- Operating income
- -72,979,000 USD
- Net income
- -58,293,000 USD
- Operating cash flow
- Not available